Press release
Aspiration & Biopsy Needles Market Growth and Restrain Factors Analysis Report
According to the latest research by InsightAce Analytic, the Global Aspiration & Biopsy Needles Market Size is valued at USD 1.14 Bn in 2025 and is predicted to reach USD 2.28 Bn by the year 2035 at a 7.8% CAGR during the forecast period for 2026 to 2035.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1989
The aspiration and biopsy needles market is witnessing robust growth, largely driven by the rising global burden of cancer. Data from the International Agency for Research on Cancer (IARC) indicate that approximately 17.0 million new cancer cases and 9.5 million cancer-related deaths were reported worldwide in 2018, with forecasts projecting a significant increase to 27.5 million new cases and 16.3 million deaths by 2040.
The growing prevalence of cancer has substantially increased the demand for reliable and accurate diagnostic solutions, particularly aspiration and biopsy needles, which play a critical role in tissue sampling for definitive cancer diagnosis. Moreover, there is a growing preference for minimally invasive diagnostic techniques, such as fine-needle aspiration (FNA), owing to their enhanced safety profile, lower procedural costs, and reduced patient discomfort and recovery time compared to conventional surgical biopsy methods.
List of Prominent Players in the Aspiration & Biopsy Needles Market:
• CONMED Corporation (US)
• Medtronic Plc (Ireland)
• Olympus Corporation (Japan)
• Becton, Dickinson and Company (US)
• Boston Scientific Corporation (US)
• Cook Group Incorporated (US)
• Argon Medical Devices, Inc (US)
• INRAD Inc. (US)
• Somatex Medical Technologies (Germany)
• Stryker Corporation (US)
• Cardinal Health (US)
• Remington Medical (US)
• Rantac Corporation (US)
• HAKKO CO., LTD (Japan)
• Merit Medical Systems (US)
Market Dynamics:
Drivers-
The rising global incidence of cancer represents a key driver of growth in the aspiration and biopsy needles market. Contributing factors include lifestyle modifications, poor dietary patterns, and increased tobacco use. Estimates from the International Agency for Research on Cancer (IARC) report approximately 17.0 million new cancer diagnoses and 9.5 million cancer-related deaths worldwide in 2018. Future projections suggest a substantial increase, with new cancer cases expected to reach 27.5 million and associated deaths rising to 16.3 million by 2040, primarily due to population growth and an aging demographic.
Curious about this latest version of the report? @
https://www.insightaceanalytic.com/enquiry-before-buying/1989
Challenges:
Biopsy needle procedures, including core biopsy and fine-needle aspiration techniques, involve inherent clinical risks, particularly the potential for infection. These risks are associated with tissue extraction through skin penetration, which may expose patients to infectious agents. The continued practice of needle reuse in certain developing regions further heightens infection risk. Despite clear guidelines from healthcare authorities and manufacturers discouraging the reuse of disposable needles, this issue remains a persistent challenge impacting market growth.
Regional Trends:
The Asia-Pacific region is rapidly emerging as a significant growth area for the aspiration and biopsy needles market, supported by increased investments in healthcare infrastructure and government initiatives aimed at improving cancer awareness and early detection. Enhanced participation from public health agencies and insurance providers in expanding access to cancer diagnostics and screening, along with rising research and development activities, is further stimulating market expansion. Additionally, rapid urbanization and population growth in key emerging economies such as China, India, and South Korea are expected to contribute to higher cancer incidence rates, thereby reinforcing strong market growth prospects in the region.
Recent Developments:
• In July 2023, Endoscopy clinical division of Cook Medical announces the launch of the EchoTip ProCore® 20 gauge needle with ReCoil StyletTM, the newest addition to the EchoTip ProCore® product portfolio. The flexible design of this needle enables physicians to acquire histological samples from challenging anatomical locations1.
• In Jan 2021, SOMATEX Medical Technologies GmbH was acquired by Hologic, Inc. for about $64 Mn, according to the company's announcement. SOMATEX provided Hologic with additional knowledge and skills to continue expanding its breast health portfolio by specialising in the development and production of minimally invasive devices in the fields of cancer diagnosis, biopsy, and interventional specialty.
Get Specific Chapter/Information From The Report:
https://www.insightaceanalytic.com/customisation/1989
Segmentation of Aspiration & Biopsy Needles Market-
By Product-
• Biopsy Needle
o Core Biopsy Needles
o Vacuum-Assisted Biopsy Needles
• Aspiration Needle
By Application-
• Tumor/Cancer Application
o Breast Cancer
o Lung Cancer
o Colorectal Cancer
o Prostate Cancer
o Kidney Cancer
o Bone & Bone Marrow Cancer
o Other Cancers
• Wound Applications
• Other Applications
By Procedure-
• Image-Guided
o Ultrasound-Guided Procedures
o Stereotactic Procedures
o CT-Guided Procedures
o MRI -Guided Procedures
o Other Image-Guided Procedures
• Non-image-guided
By End-User-
• Hospitals & Surgical Centers
• Ambulatory Care Centers
• Diagnostic Clinics & Pathology Laboratories
• Research & Academic Institutes
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get More Information: @
https://www.insightaceanalytic.com/report/aspiration--biopsy-needles-market/1989
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.
Contact Us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Official Site Visit: www.insightaceanalytic.com
Tel.: +1 607 400-7072
Email: info@insightaceanalytic.com
Follow US On :
LinkedIn @ https://www.linkedin.com/company/insightace-analytic-pvt-ltd/
Twitter @ https://x.com/MInsightace
YouTube @ https://www.youtube.com/@InsightAceAnalytic
Instagram @https://www.instagram.com/insight_ace_analytic/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Aspiration & Biopsy Needles Market Growth and Restrain Factors Analysis Report here
News-ID: 4338882 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Biophotonics Market Size, Share and Trends Analysis Report 2025-2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Biophotonics Market- (By Application (Microscopy, See-through Imaging, Light Therapy, Biosensors, Spectro Molecular, Inside Imaging, Surface Imaging (endoscopy)), By Technology (In-vivo, In-vitro), By End-Use (Medical Therapeutics, Medical Diagnostics, Others (non-medical applications))), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Biophotonics Market is valued at US$ 61.18…
Bioresorbable Vascular Scaffold Market Exclusive Report on Current Trends and Fu …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bioresorbable Vascular Scaffold Market- (By Product Type (Enviroximes-eluting Device, Novalis's-eluting Device, Sirolimus-eluting Device. Others), By Disease Type (Coronary Artery Disease, Peripheral Artery Disease), By Material Type (Poly-L-Lactic Acid (PLLA), Tyrosine-derived Polycarbonate, Others), By End-user (Hospital, Ambulatory Surgical Center, Cardiac Catheterization Lab, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research…
RFID in Healthcare Market Dynamics Shaped by High Initial Implementation Costs I …
The global RFID in healthcare market is estimated to reach over USD 33.4 Billion by the year 2034, exhibiting a CAGR of 17.0% during the forecast period.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1419
Radio-frequency identification (RFID) technology employs radio waves to transmit data via RFID tags affixed to various assets, enabling precise identification and tracking. In the healthcare sector, RFID adoption is steadily increasing for…
Newborn Screening Market Growth Driven by Rising Incidence of Congenital Disorde …
"Newborn Screening Market" in terms of revenue was estimated to be worth 935.17 Million in 2022 and is poised to reach 2113.45 Million by the year 2031, growing at a CAGR of 9.8 % from 2023 to 2031 according to a new report by Insight Ace Analytic.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1433
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global Newborn Screening…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
